EMA committee recommends marketing authorization for STADA’s denosumab biosimilars: Bad Vilbel, Germany Tuesday, September 23, 2025, 11:00 Hrs [IST] STADA received positive opin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback